Iran Stands Firm as Trump Rejects Peace Counteroffer Escalating Middle East Tensions Global Markets Edge Higher as USIran Talks Offer Hope but Oil Above 100 and Hormuz Disruption Persist Managing Director Uses Everyday Purchases to Instill Financial Literacy in Children Stereotaxis STXS Analyst Target Suggests Potential 1247 Upside Estate Planning Questions Handling CDs for a Parent in Hospice Care Microsoft Signals Potential 190 Billion Capital Spending by 2026 Amid Rising Memory Costs MATV Q1 2026 Earnings Significant EPS Beat Amid Cost Discipline and Strategic Focus STNG Q1 2026 Earnings EPS Beats Estimates by 166 as Tanker Market Remains Firm Tetra Tech Inc TTEK Q1 2026 Earnings EPS Beats Estimates on Operational Discipline Crown Crafts Inc CRWS Q1 2026 Earnings Reports EPS of 014 as Stock Gains ADAM Q1 2026 Earnings Strong Earnings Beat Drives Stock Up 247 MTVA Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline BlackRock Enhanced Large Cap Core Fund CII Rises 163 as Price Approaches Key Resistance Level Flag Ship Acquisition Corp Rights FSHPR Trading at 008 Amidst Stagnant Price Action New York Times NYT Holds Steady Near 75 as Digital Subscription Growth Fuels Modest Gains Amerant Bancorp AMTB Edges Higher Amid Sector Stability Luda Technology Rallies 4 as Shares Test Key Resistance Near 488 UK Labours Capital Gains Tax Proposal Implications for Investors and Markets KB Home Q1 2026 Earnings Modest EPS Beat Amid Stabilizing Housing Market Glimpse Group Shares Dip as Stock Hovers Near Key Support Levels GGRP DUO Q2 2021 Earnings Massive EPS Miss Highlights Continued Challenges SEVN Q1 2026 Earnings Slight EPS Beat Amidst Market Headwinds CRNX Q1 2026 Earnings EPS Surprise Beats Estimates as PreRevenue Biotech Advances Pipeline SDRL Q1 2026 Earnings NarrowerthanExpected Loss Boosts Investor Sentiment BWEN Q1 2026 Earnings Strong EPS Beat Amid Revenue Uncertainty Shares Decline BancFirst Corporation BANF Q1 2026 Earnings Solid EPS Beat Amid Steady Operating Performance CNTA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment